Chen Shiqi, Wu Xiaoxiao, Li Tong, Li Yang, Wang Baofu, Cheng Weiting, Teng Yu, Yang Jingjing, Meng Hui, Wang Lei, Lu Ziwen, Jiang Yangyang, Wang Yahong, Zhao Mingjing
Key Laboratory of Chinese Medicine of Ministry of Education and Beijing, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing 100700, China.
Department of Cardiology, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing 100700, China.
Evid Based Complement Alternat Med. 2021 Nov 27;2021:4010607. doi: 10.1155/2021/4010607. eCollection 2021.
Some postmarketing Chinese patent formulas have been widely used to treat atherosclerosis (AS) and play critical roles in Chinese healthcare. However, the usage of these herbs is yet controversial due to unclear effects and lack of understanding of the mechanism of action. With the modernization of traditional Chinese formulas, we are to elucidate the atheroprotective properties of these remedies from successful postmarketing experiments .
In this systematic review, we critically searched the databases, applied stringent criteria, assessed the methodological quality, and examined the current evidence .
Consequently, 60 studies were included in the present qualitative synthesis. Data on models, high-fat diet, intervention time, outcome measures, efficacy, and mechanisms were collected. Finally, 23 formulas that could alleviate AS were correlated to the amelioration of plaques, improvement of plaque stability, modification of lipid level and lipid metabolism, and the effects of anti-inflammation and antioxidant stress with multiple components and targets. However, the methodological quality was low and incomplete among the included literature.
Thus, taken together, the studies on postmarketing Chinese patent formulas would provide a novel approach to improve the treatment of AS, and rigorously designed studies would provide high-quality evidence.
一些上市后中药配方已被广泛用于治疗动脉粥样硬化(AS),在中国医疗保健中发挥着关键作用。然而,由于其作用效果不明确以及对作用机制缺乏了解,这些草药的使用仍存在争议。随着中药配方的现代化,我们将通过成功的上市后实验阐明这些药物的抗动脉粥样硬化特性。
在本系统评价中,我们严格检索数据库,应用严格标准,评估方法学质量,并审查现有证据。
因此,本定性综合分析纳入了60项研究。收集了关于模型、高脂饮食、干预时间、结局指标、疗效和机制的数据。最后,23种可缓解AS的配方与斑块改善、斑块稳定性提高、血脂水平和脂质代谢改变以及多成分多靶点的抗炎和抗氧化应激作用相关。然而,纳入文献中的方法学质量较低且不完整。
因此,综合来看,关于上市后中药配方的研究将为改善AS的治疗提供一种新方法,而严格设计的研究将提供高质量证据。